Safety of room temperature stable recombinant activated factor VII (VII25) in patients with haemophilia A or B with inhibitors: results from the prospective, non-interventional smart-7 study

Kavakli, K.Chambost, H.Demartis, F.Sommer, L.Zak, M.Benson, G.2019-10-272019-10-2720161351-82161365-2516https://hdl.handle.net/11454/53075eninfo:eu-repo/semantics/closedAccessSafety of room temperature stable recombinant activated factor VII (VII25) in patients with haemophilia A or B with inhibitors: results from the prospective, non-interventional smart-7 studyConference Object225252WOS:000374485500082Q2